FREMONT, Calif., June 22, 2022 /PRNewswire/ — The healthcare research team at BIS Research has conducted an in-depth analysis on the global digital biomanufacturing market and have drawn the conclusion on its future demand. According to the report published on the global digital biomanufacturing market, the market is projected to reach $55.56 billion in terms of revenue by 2031, at a CAGR of 13.12%.
The global digital biomanufacturing market stands to benefit from the growing need for digital biomanufacturing among various industries such as biopharmaceuticals worldwide.
New and improved manufacturing technologies such as continuous biomanufacturing and 3D bioprinting may necessitate the integration of several data sources, deep data analysis, and model-based digital biomanufacturing (DB) predictions. They also significantly improve older platforms.
The detailed study is a compilation of 09 market data tables and 169 figures spread through 203 pages and in-depth TOC on “Global Digital Biomanufacturing Market – Analysis and Forecast, 2022-2031”
Reasons to Buy This Report
This exclusive report on the global digital biomanufacturing market will help you in the following ways:
Analyst’s Take on the Market:
According to Swati Sood, Principal Analyst – BIS Research, “The global digital biomanufacturing market is expected to witness significant growth in emerging economies due to factors such as increasing demand for automated biomanufacturing, as well as the rising technology integration across countries such as Japan, South Korea, India, and Brazil.”
View the report on Global Digital Biomanufacturing Market
Key Companies Operating in the Market and Competitive Landscape
Some of the key players operating in the market include – Agilent Technologies Inc., Danaher Corporation, Donaldson Company, Inc., Emerson Electric Co., General Electric Company, Honeywell International Inc., SAP SE, Siemens Healthineers AG, Bota Biosciences, Culture Biosciences, e-matica srl, Exponential Genomics, Inc. (Xenomics), FabricNano, OVO Biomanufacturing and Symphony Innovation, LLC
In the past few years, the global digital biomanufacturing market has witnessed several strategic and technological developments undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are funding activities, mergers and acquisitions (M&A), partnerships, alliances, business expansions, regulatory and legal activities, and new offerings. The preferred strategy for companies has been new offerings of products followed by partnerships, alliances, and business expansions.
Who should buy this report?
The companies which are manufacturing and commercializing digital biomanufacturing-based foods and beverages, clothing and apparel, packaging, producing raw digital biomanufacturing, mushroom-based companies, pharmaceutical companies, research institutions, and regulatory bodies.
Request a Sample of this Report
Key Questions Answered in the Report:
BIS Research Related Market Studies:
Next Generation Biomanufacturing Market
About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.
Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.
BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.
Contact:
Head of Marketing
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://bisresearch.com/news
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch
Logo: https://healthtechnologynet.com/wp-content/uploads/2022/06/BIS_Research_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/increased-demand-for-biologics-to-lead-the-digital-biomanufacturing-market-suggests-the-latest-report-from-bis-research-301572751.html
SOURCE BIS Research
CHICAGO, June 14, 2024 /PRNewswire/ -- Projected to grow at a CAGR of 10.5%, the…
The Company expects that the application for OTC clearance will shortly be followed by pursuit…
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other…
More than 3 million public school children lack the glasses they need. Vision To Learn…
$6 million upfront with up to an additional $18 million of aggregate gross proceeds upon…
Clinical trials for AI Nose-powered Ainos Flora device moves forward with 75 meaningful case results,…